Loading company…
Vigene Biosciences supplies gene delivery tools, including AAV, lentivirus and adenovirus products for virology and gene therapy.
Founded in 2012 and based in Maryland, US, Vigene Biosciences, Inc. develops gene delivery technologies for virology and gene therapy. Its offerings include AAV, lentivirus and adenovirus-based products, custom services, and ready-to-ship genome-wide human cDNA ORFs on adenoviral or lentiviral vectors. Other products include AAV shRNA constructs, control GFP viruses, AAV biosensors developed with Janelia Research Campus, and AAV alpha-synuclein vectors developed with The Michael J Fox Foundation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in